
Triple Ring Technologies is a corporate growth lab and co-development company headquartered in Silicon Valley, with offices in Boston, Toronto, and Copenhagen. They partner with clients in medtech, life sciences, and agriculture & environment to create new technologies, launch innovative projects, and start new ventures. Their capabilities span early R&D, product development, manufacturing, regulatory approval, market access, strategic investment, and incubation. With over 100 technologists and experts, they focus on areas like robotics, AI, sensors, engineered biology, and sustainable supply chains, aiming to empower clinicians and translate lab breakthroughs to clinical applications.

Triple Ring Technologies is a corporate growth lab and co-development company headquartered in Silicon Valley, with offices in Boston, Toronto, and Copenhagen. They partner with clients in medtech, life sciences, and agriculture & environment to create new technologies, launch innovative projects, and start new ventures. Their capabilities span early R&D, product development, manufacturing, regulatory approval, market access, strategic investment, and incubation. With over 100 technologists and experts, they focus on areas like robotics, AI, sensors, engineered biology, and sustainable supply chains, aiming to empower clinicians and translate lab breakthroughs to clinical applications.
Headquarters: Newark, California (Silicon Valley)
Business model: On-demand technology and product-creation lab for regulated industries
Core areas: Medtech, life sciences, agriculture & environment; robotics, AI, sensors, engineered biology
Team size: Approximately 93–250 employees (sources show 93 and range 101–250)
Recent funding signal: Grant recorded Jan 11, 2022; growth-capital investment from 1315 Capital announced Feb 1, 2024
Bridging early-stage technology development and regulated commercialization for medical devices, regulated hardware, and related fields.
2004
Medical device / regulated hardware / product development lab
Most recent disclosed funding on Crunchbase listed as a grant dated Jan 11, 2022.
1315 Capital announced a growth-capital investment in Triple Ring Technologies.
Triple Ring announced an investment in One Health Group and a technology partnership.
“Triple Ring has received a grant (Jan 11, 2022) and a growth-capital investment from 1315 Capital (Feb 1, 2024); third-party listings also indicate multiple investors including U.S. EPA and FDA on record.”